AI for diagnostic support for everyone
Mediot AI and Roche join forces to democratize access to medical diagnostics in Africa through artificial intelligence and connected health technologies.
This strategic partnership aims to bring reliable and innovative diagnostic solutions closer to African populations, combining Roche's global diagnostic expertise and Mediot AI's artificial intelligence capabilities, in the service of fairer and more accessible health.
The alliance between global pharmaceutical expertise and AI innovation
Mediot AI, a subsidiary of the Moroccan group ABA Technology, has entered into a strategic agreement with Roche, a global leader in the pharmaceutical industry, to deploy large-scale tele-biology solutions across the African continent. This collaboration aims to bring medical diagnostics closer to populations, particularly in under-equipped or remote areas lacking traditional healthcare infrastructure.
By combining Roche's clinical and diagnostic expertise with the technological agility of Mediot AI, this partnership creates a solid foundation to accelerate access to reliable and high-precision medical analyses.
An integrated technology for more informed medical decisions
This partnership is based on the integration of Roche's advanced diagnostic solutions with the Mediot AI data platform, driven by artificial intelligence and an AIoT ecosystem based on Medical Fusion AI technology, specifically designed for healthcare environments.
This convergence allows for the analysis, interpretation, and enhancement of biological data in real-time, thereby providing healthcare professionals with intelligent, connected decision-making support tools tailored to the realities of the African field.
Reduce inequalities and strengthen the autonomy of communities
Beyond technological innovation, this alliance carries a strong vision: to reduce the inequalities in access to care, strengthen the autonomy of local communities, and build a sustainable model of connected health in Africa.
In a context where millions of people remain without a reliable diagnosis, this initiative aims to make precise medical analyses accessible across the entire continent, relying on distributed connectivity, smart diagnostics, and artificial intelligence. It paves the way for a new generation of care pathways: earlier, more efficient, and guided by AI to sustainably improve health outcomes.
